About Gan & Lee Pharmaceutical
Gan & Lee Pharmaceutical is a company based in Beijing (China) founded in 1988 by Zhongru Gan.. Gan & Lee Pharmaceutical has raised $46.46 million across 2 funding rounds from investors including Goldman Sachs and Qiming Venture Partners.
- Headquarter Beijing, China
- Founders Zhongru Gan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$412.36 M (USD)16.66as on Dec 31, 2024
-
Net Profit
$84.21 M (USD)80.75as on Dec 31, 2024
-
EBITDA
$75.98 M (USD)36.24as on Dec 31, 2024
-
Total Equity Funding
$46.46 M (USD)
in 2 rounds
-
Latest Funding Round
$30.23 M (USD), Series B
May 01, 2011
-
Investors
Goldman Sachs
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Gan & Lee Pharmaceutical
Gan & Lee Pharmaceutical has successfully raised a total of $46.46M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30.23 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $30.2M
-
First Round
First Round
(01 May 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2011 | Amount | Series B - Gan & Lee Pharmaceutical | Valuation |
investors |
|
| May, 2010 | Amount | Series A - Gan & Lee Pharmaceutical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gan & Lee Pharmaceutical
Gan & Lee Pharmaceutical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Goldman Sachs and Qiming Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gan & Lee Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gan Lee Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gan & Lee Pharmaceutical Comparisons
Competitors of Gan & Lee Pharmaceutical
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gan & Lee Pharmaceutical
Frequently Asked Questions about Gan & Lee Pharmaceutical
When was Gan & Lee Pharmaceutical founded?
Gan & Lee Pharmaceutical was founded in 1988 and raised its 1st funding round 22 years after it was founded.
Where is Gan & Lee Pharmaceutical located?
Gan & Lee Pharmaceutical is headquartered in Beijing, China.
Is Gan & Lee Pharmaceutical a funded company?
Gan & Lee Pharmaceutical is a funded company, having raised a total of $46.46M across 2 funding rounds to date. The company's 1st funding round was a Series A of $16.24M, raised on May 01, 2010.
What is the annual revenue of Gan & Lee Pharmaceutical?
Annual revenue of Gan & Lee Pharmaceutical is $412.36M as on Dec 31, 2024.
What does Gan & Lee Pharmaceutical do?
Gan Lee Pharmaceutical was founded in 1988 in Beijing, China, within the biopharmaceutical sector. Research, development, manufacturing, and global distribution of insulin analogs and related medical devices are conducted by the company. Commercial partnerships have been established to support market expansion across international regions. Operations emphasize production of novel insulin products for health applications worldwide.
Who are Gan & Lee Pharmaceutical's investors?
Gan & Lee Pharmaceutical has 2 investors. Key investors include Goldman Sachs, and Qiming Venture Partners.